AIR-P Presents: COVID-19 Vaccine, I/DD Populations, and the Needle Anxiety Program at UCLA

AIR-P Presents: COVID-19 Vaccine, I/DD Populations, and the Needle Anxiety Program at UCLA

Tuesday, February 16, 2021
4:00 p.m. - 5:00 p.m. ET
Location: Zoom Webinar

Blue Button with text Register

Webinar Description:

Immunizations are crucial to protect all people from vaccine-preventable illnesses. Some studies suggest that autistic individuals have lower rates of immunizations, for reasons that are not entirely clear. Multiple organizations have called for individuals with intellectual and developmental disabilities to be prioritized in COVID-19 vaccination distribution. Vaccine hesitancy and needle phobia are two likely contributors towards lower vaccination rates. One of the initial intervention projects from the AIR-P focuses on reducing needle anxiety and improving immunization rates among autistic individuals. This intervention was developed as a pilot to address needle anxiety in conjunction with Pfizer and the American Academy of Pediatrics (AAP) for use in an Improving Pediatric Immunization Care collaborative but has not been widely implemented. The AIR-P network provides an opportunity to implement this needle anxiety intervention in multiple sites. Measures of success for this intervention would include vaccination rates among autistic individuals and satisfaction with the vaccine administration process.

Presenters:

Asian american woman wearing a blue suit smiling at the camera.Alice Kuo, MD, PhD, MBA is the Principal Investigator of the AIR-P. She is a Professor of Internal Medicine and Pediatrics at the David Geffen School of Medicine at UCLA, and of Health Policy and Management in the Fielding UCLA School of Public Health. She is also Chief of Medicine-Pediatrics at UCLA. Her research interests include access to and delivery of developmental services, cognitive and language development in young minority children, and services for children and adults with autism and other neurodevelopmental disorders. Since 2014, she has been the Director of the Maternal and Child Health Bureau (MCHB)-funded Health Care Transitions Research Network (HCT-RN) for Autism Spectrum Disorder. In addition to her research, Dr. Kuo has been involved in educational programs at several levels, from undergraduate students to post-graduate fellows. Since 2006, she has been the Director of the MCHB-funded Pathways for Students into Health Professions for disadvantaged undergraduate students interested in public health and health professional careers. At the post-graduate level, Dr. Kuo is the Director of the UCLA Combined Internal Medicine and Pediatrics Residency Program, which she founded in 2003. In 2016, she became the Director of the University of California Leadership Education in Neurodevelopmental Disabilities (UC-LEND) program. At the national level, she has been the chair of the Health Care Transition Committee for the Medicine-Pediatrics Program Directors Association since 2012. Dr. Kuo received a BA in Biology from Harvard University, her MD from UCLA, her PhD in Educational Psychology with a focus on Early Childhood and Special Education from the Graduate School of Education and Information Studies at UCLA, and her MBA in Healthcare Administration from the University of Massachusetts Isenberg School of Management.

 

Please Note:

  • There is no cost for this webinar.
  • CEUs are not offered for this webinar.
  • This webinar will be held on the Zoom Platform. You can test your connection with Zoom before joining the meeting here.
  • For disability accommodations, email [email protected]
  • This webinar will be archived.